Sign up to save your podcasts
Or
Share Promising Prostate Cancer Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Promising Prostate Cancer Therapy
The theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies.
View all episodes
By TheBrief.HealthThe theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies.